Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Molloy SF"'
Cryptococcal antigen (CrAg) is detectable in blood prior to the onset of symptomatic cryptococcal meningitis, a leading cause of death among people living with advanced HIV disease globally. Highly sensitive assays can detect CrAg in blood, and scree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::70f9c3ccd66784582ddeaf863f9a149a
https://openaccess.sgul.ac.uk/id/eprint/114736/1/ciac675.pdf
https://openaccess.sgul.ac.uk/id/eprint/114736/1/ciac675.pdf
Cryptococcal meningitis is the leading cause of adult meningitis in patients with HIV, and accounts for 15% of all HIV-related deaths in sub-Saharan Africa. The mainstay of management is effective antifungal therapy, despite a limited arsenal of anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::10ab371cf2cbd08697dbddf136cfae53
Autor:
Tenforde, MW, Boyer-Chammard, T, Muthoga, C, Tawe, L, Milton, T, Rulaganyang, I, Lechiile, K, Rukasha, I, Leeme, TB, Govender, NP, Ngidi, J, Mine, M, Molloy, SF, Harrison, TS, Lortholary, O, Jarvis, JN
High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::23c761214ebf45455508397df16e77a6
https://researchonline.lshtm.ac.uk/id/eprint/4661272/1/JCM.02307-20.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4661272/1/JCM.02307-20.pdf
Autor:
Chen, T, Mwenge, L, Lakhi, S, Chanda, D, Mwaba, P, Molloy, SF, Gheorghe, A, Griffiths, UK, Heyderman, RS, Kanyama, C, Kouanfack, C, Mfinanga, S, Chan, AK, Temfack, E, Kivuyo, S, Hosseinipour, MC, Lortholary, O, Loyse, A, Jaffar, S, Harrison, TS, Niessen, LW, ACTA Trial Team
Background\ud Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ac8abe6ccc1d99ff9013e3820aedad89
https://openaccess.sgul.ac.uk/id/eprint/110685/6/ciy971.pdf
https://openaccess.sgul.ac.uk/id/eprint/110685/6/ciy971.pdf
Autor:
Molloy, SF, Bradley, J, Karunaharan, N, Mputu, M, Stone, N, Phulusa, J, Chawinga, C, Gaskell, K, Segula, D, Ming, D, Peirse, M, Chanda, D, Lakhi, S, Loyse, A, Kanyama, C, Heyderman, RS, Harrison, TS
We assessed the effect of fluconazole 1200 mg/day on the QT interval in cryptococcal meningitis patients. Mean corrected QT (QTc) change from baseline to day 7 was 10.1 ms (IQR: −28 to 46 ms) in the fluconazole treatment group and −12.6 ms (IQR:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::7416d1846fb9a20feaadfe26ea928cd8
http://hdl.handle.net/10044/1/95234
http://hdl.handle.net/10044/1/95234
Autor:
Pasquier, E, Kunda, J, De Beaudrap, P, Loyse, A, Temfack, E, Molloy, SF, Harrison, TS, Lortholary, O
Cryptococcal meningitis (CM) is the primary cause of meningitis in HIV-infected adults and an emerging disease in HIV-seronegative individuals. No literature review has studied the long-term outcome of CM. We performed a systematic review on the long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7ecdfce54d9a866fdf8a96d86bc0efcd
Publikováno v:
Epidemiology & Infection; Jun2011, Vol. 139 Issue 6, p946-954, 9p
Autor:
Hurt W; Institute of Infection and Immunity, St George's University of London, London, UK whurt@sgul.ac.uk.; Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK., Youngs J; Institute of Infection and Immunity, St George's University of London, London, UK.; Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK., Ball J; Adult Critical Care, St George's University Hospitals NHS Foundation Trust, London, UK., Edgeworth J; Clinical Infection and Microbiology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Hopkins P; Adult Critical Care, King's College Hospital NHS Foundation Trust, London, UK., Jenkins DR; Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK., Leaver S; Adult Critical Care, St George's University Hospitals NHS Foundation Trust, London, UK., Mazzella A; Institute of Infection and Immunity, St George's University of London, London, UK., Molloy SF; Institute of Infection and Immunity, St George's University of London, London, UK., Schelenz S; Medical Microbiology, King's College Hospital NHS Foundation Trust, London, UK., Wise MP; Adult Critical Care, University of Wales Hospital, Cardiff, UK., White PL; Microbiology, Public Health Wales, Cardiff, UK., Yusuff H; Adult Critical Care, University Hospitals of Leicester NHS Trust, Leicester, UK., Wyncoll D; Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, UK., Bicanic T; Institute of Infection and Immunity, St George's University of London, London, UK.; Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK.
Publikováno v:
Thorax [Thorax] 2023 Dec 15; Vol. 79 (1), pp. 75-82. Date of Electronic Publication: 2023 Dec 15.
Autor:
Sephton-Clark P; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Temfack E; Internal Medicine Unit, Douala General Hospital, Douala, Cameroon.; Institut Pasteur, Molecular Mycology Unit, CNRS UMR 2000, Paris, France., Tenor JL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Toffaletti DL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Loyse A; Institute of Infection and Immunity, St George's University of London, London, UK.; Clinical Academic Group in Infection, St George's University Hospital, London, UK., Molloy SF; Institute of Infection and Immunity, St George's University of London, London, UK., Perfect JR; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Bicanic T; Institute of Infection and Immunity, St George's University of London, London, UK.; Clinical Academic Group in Infection, St George's University Hospital, London, UK., Harrison TS; Institute of Infection and Immunity, St George's University of London, London, UK.; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Lortholary O; Department of Infectious Diseases and Tropical Medicine, Paris Cité University, Necker-Enfants Malades Hospital, AP-HP, IHU Imagine, Paris, France.; Mycology Department and National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Paris, France., Kouanfack C; Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.; Day Hospital, Hospital Central Yaoundé, Yaoundé, Cameroon.; Research Center for Emerging and Re-emerging Diseases, Cameroon Baptist Convention Health Services (CBCHS), Yaoundé, Cameroon., Cuomo CA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Publikováno v:
Medical mycology [Med Mycol] 2023 Dec 01; Vol. 61 (12).
Autor:
Mfinanga S; National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK., Kanyama C; University of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe, Malawi., Kouanfack C; University of Dschang, Dschang, Cameroon., Nyirenda S; Zomba Central Hospital, Zomba, Malawi., Kivuyo SL; National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania., Boyer-Chammard T; Unité de Mycologie Moléculaire, Institut Pasteur, Université de Paris, Centre National de la Recherche Scientifique, Paris, France., Phiri S; Lighthouse Trust, Lilongwe, Malawi., Ngoma J; Kamuzu Central Hospital, Lilongwe, Malawi., Shimwela M; Amana Hospital, Dar es Salaam, Tanzania., Nkungu D; Mwananyamala Hospital, Dar es Salaam, Tanzania., Fomete LN; Yaoundé Central Hospital, Yaoundé, Cameroon., Simbauranga R; National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania., Chawinga C; University of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe, Malawi., Ngakam N; Yaoundé Central Hospital, Yaoundé, Cameroon., Heller T; Lighthouse Trust, Lilongwe, Malawi., Lontsi SS; Yaoundé Central Hospital, Yaoundé, Cameroon., Aghakishiyeva E; Institute for Infection and Immunity, St George's University of London, London, UK., Jalava K; Wood Street Veterinary Hospital, Barnet, UK., Fuller S; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK., Reid AM; Leeds Institute of Medical Education, University of Leeds, Leeds, UK., Rajasingham R; University of Minnesota, Minneapolis, MN, USA., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Hosseinipour MC; University of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe, Malawi., Beaumont E; Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, UK., Bradley J; Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, UK., Jaffar S; UCL Institute for Global Health, University College London, London, UK., Lortholary O; Unité de Mycologie Moléculaire, Institut Pasteur, Université de Paris, Centre National de la Recherche Scientifique, Paris, France; Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris, Institut Hospitalier Universitaire Imagine, Paris, France., Harrison T; Institute for Infection and Immunity, St George's University of London, London, UK., Molloy SF; Institute for Infection and Immunity, St George's University of London, London, UK., Sturny-Leclère A; Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, France., Loyse A; Unité de Mycologie Moléculaire, Institut Pasteur, Université de Paris, Centre National de la Recherche Scientifique, Paris, France; Institute for Infection and Immunity, St George's University of London, London, UK. Electronic address: aloyse@sgul.ac.uk.
Publikováno v:
The lancet. HIV [Lancet HIV] 2023 Oct; Vol. 10 (10), pp. e663-e673.